RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting. (2021)

First Author: Meade A
Attributed to:  Method - Efficient and effective conduct of clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cct.2021.106481

PubMed Identifier: 34538401

Publication URI: http://europepmc.org/abstract/MED/34538401

Type: Journal Article/Review

Volume: 108

Parent Publication: Contemporary clinical trials

ISSN: 1551-7144